Search
Descriptor English: Antibodies, Blocking
Descriptor Spanish: Anticuerpos Bloqueadores
Descriptor anticuerpos bloqueantes
Entry term(s) anticuerpos aumentadores
anticuerpos favorecedores
Scope note: Anticuerpos que inhiben la reacción entre ANTÍGENOS y otros anticuerpos o linfocitos T sensibilizados (por ejemplo, anticuerpos de la clase de INMUNOGLOBULINA G que compiten con los anticuerpos IgE por el antígeno, bloqueando así una respuesta alérgica). Los anticuerpos bloqueantes que se unen a los tumores y que impiden la destrucción de las células tumorales por los LINFOCITOS T CITOTÓXICOS han recibido también la denominación de anticuerpos favorecedores. (Rosen et al., Dictionary of Immunology, 1989)
Descriptor Portuguese: Anticorpos Bloqueadores
Descriptor French: Anticorps bloquants
Entry term(s): Antibodies, Enhancing
Blocking Antibodies
Enhancing Antibodies
Tree number(s): D12.776.124.486.485.114.143
D12.776.124.790.651.114.143
D12.776.377.715.548.114.143
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D019138
Scope note: Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES (e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. (Rosen et al., Dictionary of Immunology, 1989)
Annotation: antibodies inhibiting reaction between antigen and other antibodies or sensitized T-lymphocytes: not for any antibody reaction to an antigen ( = ANTIBODIES or specific antibody); do not coordinate with ANTIBODY FORMATION for /biosyn
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
DE drug effects
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PO poisoning
RE radiation effects
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Pharm Action: Immunologic Factors
Public MeSH Note: 96
History Note: 96
DeCS ID: 32855
Unique ID: D019138
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1996/01/01
Date of Entry: 1995/06/06
Revision Date: 2005/06/30
Antibodies, Blocking - Preferred
Concept UI M0028535
Scope note Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES (e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. (Rosen et al., Dictionary of Immunology, 1989)
Preferred term Antibodies, Blocking
Entry term(s) Blocking Antibodies
Enhancing Antibodies - Narrower
Concept UI M0028534
Preferred term Enhancing Antibodies
Entry term(s) Antibodies, Enhancing



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey